Known targets — ChEMBL curated mechanism
PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Histidine SCHEMBL9294075 | 0.87 | — | — | |
| Histidine SCHEMBL5578065 | 0.85 | — | — | |
| Arginine SCHEMBL18042243 | 0.83 | MC4R (0.33) | — | |
| Arginine SCHEMBL18042251 | 0.83 | TUBB4A (0.35) | — | |
| Arginine SCHEMBL18042259 | 0.83 | TUBB4A (0.33) | — | |
| Histidine SCHEMBL9294080 | 0.82 | MC4R (0.31) | — | |
| Histidine SCHEMBL8896145 | 0.82 | — | — | |
| Arginine SCHEMBL18042250 | 0.82 | TUBB4A (0.32) | — | |
| Histidine SCHEMBL7758637 | 0.81 | CALCR (0.32) | — | |
| Histidine SCHEMBL9031032 | 0.81 | GHSR (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070166699-A1 | Combination of anti-hpv-16 and 18 antibodies and uses thereof | AMYNON BIOTECH GMBH | 2007-07-19 | — | — | US | disclosed |
| EP-1664785-A1 | COMBINATION OF ANTI-HPV-16 AND 18 ANTIBODIES AND USES THEREOF | Amynon BioTech GmbH (AT) | 2006-06-07 | — | — | EP | disclosed |
| WO-2005026731-A1 | COMBINATION OF ANTI-HPV-16 AND 18 ANTIBODIES AND USES THEREOF | AMYNON BIOTECH GMBH (AT) | 2005-03-24 | — | — | WO | disclosed |